UK MHRA approves first generic raltegravir medicines for HIV treatment
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for the first generic raltegravir medicines, designed to treat adult and pediatric HIV patients weighing at least 40 kg. This approval marks a significant step forward in the availability of affordable HIV treatment options.The new marketing authorization for generic raltegravir was granted to […]